Literature DB >> 21193141

[Recommendations for best practice for prostate biopsy].

A Ouzzane1, P Coloby, J-P Mignard, J-P Allegre, M Soulie, X Rebillard, L Salomon, A Villers.   

Abstract

OBJECTIVES: the aim of these recommendations is to help urologists to optimize prostate biopsy practice in order to improve diagnosis yield and to minimize associated morbidity.
METHODS: online systematic literature search was performed on PubMed until April 2010. Regulation texts, published guidelines and results of recent urologists practice study, were taken into consideration. Level of evidence was assigned to each recommendation.
RESULTS: patient information must be prior to the procedure and should be given through a medical exam by the physician performing the biopsies. The check for complication risk factors (allergic, infectious, hemorrhagic) had to be done preoperatively by the physician during the medical exam. The use of single systemic antibiotics is recommended and Quinolones are the drugs of choice (level of evidence 2). Biopsies should be performed on outpatient basis to assess the safety of the procedure. Transrectal route and ultrasound guidance are state-of-the-art. Local anaesthesia with peri-prostatic block is recommended (level of evidence 1). On baseline biopsies, extended 12-cores scheme should be performed. Urine retention and severe postbiopsies infections have been reported in less than 1% of cases. Optimal management of severe post-biopsies infections is based first on patient information and require hospital intravenous antibiotic therapy.
CONCLUSION: to improve the sensitivity and to reduce the risk of complication, achievement of prostate biopsies should follow a standardized procedure. 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21193141     DOI: 10.1016/j.purol.2010.07.001

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  6 in total

1.  Cephalosporins periprostatic injection: are really effective on infections following prostate biopsy?

Authors:  Gianna Pace; Luca Carmignani; Carlo Marenghi; Gabriella Mombelli; Giorgio Bozzini
Journal:  Int Urol Nephrol       Date:  2012-03-22       Impact factor: 2.370

2.  Precisely positioning the tip of an instrument inserted through an orifice with a free wrist robot: application to prostate biopsies.

Authors:  Rémi Chalard; David Reversat; Guillaume Morel; Pierre Mozer; Marie-Aude Vitrani
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-02-27       Impact factor: 2.924

3.  Outbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi Infections after Prostate Biopsies, France, 2014.

Authors:  Skerdi Haviari; Pierre Cassier; Cédric Dananché; Monique Hulin; Olivier Dauwalder; Olivier Rouvière; Xavier Bertrand; Michel Perraud; Thomas Bénet; Philippe Vanhems
Journal:  Emerg Infect Dis       Date:  2016-08       Impact factor: 6.883

4.  Limiting overdiagnosis of low-risk prostate cancer through an evaluation of the predictive value of transrectal and power Doppler ultrasonography.

Authors:  Jean Luc Sauvain; Elise Sauvain; Roger Papavero; Didier Louis; Paul Rohmer
Journal:  J Ultrasound       Date:  2016-09-29

5.  Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications.

Authors:  Nigel P Murray; Eduardo Reyes; Leonardo Badínez; Nelson Orellana; Cynthia Fuentealba; Ruben Olivares; José Porcell; Ricardo Dueñas
Journal:  J Oncol       Date:  2013-04-17       Impact factor: 4.375

6.  Hepatitis C transmission after prostate biopsy.

Authors:  Karim Ferhi; Morgan Rouprêt; Pierre Mozer; Guillaume Ploussard; Alain Haertig; Alexandre de La Taille
Journal:  Case Rep Urol       Date:  2013-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.